Dr. Christopher A. Semder, MD
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Medical school
- Jc Edwards School of Medicine, Marshall University (2007)
- Years since graduation
- 19
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 1,982
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Medical school: Jc Edwards School of Medicine, Marshall University
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
KY license 47319 -
Cardiovascular Disease Physician
KY license 47319 -
Hospitalist Physician
TN license 45369
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Uofl Health - Jewish Hospital and Mary & Elizabeth Hospital Louisville, KY
- Baptist Health Louisville Louisville, KY
- Baptist Health Hardin Elizabethtown, KY
- Baptist Health Floyd New Albany, IN
- Baptist Health Lagrange La Grange, KY
Medical groups
- Baptist Health Medical Group Inc (2,472 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,982
- Services billed
- 3,688
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,979 | 1,592 |
| Established patient office or other outpatient visit, 30-39 minutes | 539 | 474 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 510 | 463 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 251 | 153 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 93 | 91 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 59 | 59 |
| New patient office or other outpatient visit, 45-59 minutes | 57 | 57 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 34 | 28 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 28 | 27 |
| Heart rhythm recording of continous external ekg over 8-15 days | 21 | 21 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Atorvastatin Calcium Other prescribers in Louisville, KY | 304 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Louisville, KY | 291 |
| Carvedilol Other prescribers in Louisville, KY | 251 |
| Metoprolol Succinate Other prescribers in Louisville, KY | 243 |
| Eliquis (apixaban) Other prescribers in Louisville, KY | 239 |
| Metoprolol Tartrate Other prescribers in Louisville, KY | 197 |
| Furosemide Other prescribers in Louisville, KY | 183 |
| Amlodipine Besylate Other prescribers in Louisville, KY | 162 |
| Losartan Potassium Other prescribers in Louisville, KY | 158 |
| Rosuvastatin Calcium Other prescribers in Louisville, KY | 121 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 7 companies reported 12 payments worth $611 in total to this clinician.
| Edwards Lifesciences Corporation | $215 |
|---|---|
| Medtronic, Inc. | $203 |
| Boston Scientific Corporation | $94.06 |
| Pfizer Inc. | $39.66 |
| Abbott Laboratories | $20.99 |
| Teleflex LLC | $20.17 |
| Bridgebio Pharma, Inc. | $18.28 |
| Food and Beverage | $611 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $4,767 in research payments for these studies, mostly to the institutions running them.
- NCT03309332--AMPLATZER PFO Occluder Post Approval Study
Abbott Laboratories - Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism
Boston Scientific Corporation · Active, not recruiting · NCT04790370
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.